Trial Profile
Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Scorpion venom antitoxin (Primary)
- Indications Stings
- Focus Therapeutic Use
- Sponsors Birmex
- 10 Jun 2014 New trial record